000			01920 a2200529 4500
005			20250513233907.0
264		0	_c20010628
008			200106s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/s0041-1345(00)02649-x _2doi
040			_aNLM _beng _cNLM
100	1		_aLo, A
245	0	0	_aLimited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. _h[electronic resource]
260			_bTransplantation proceedings _c
300			_a1701-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBasiliximab
650	0	4	_aDaclizumab
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aGraft Rejection _xprevention & control
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKidney Transplantation _ximmunology
650	0	4	_aMale
650	0	4	_aMycophenolic Acid _xanalogs & derivatives
650	0	4	_aPancreas Transplantation _ximmunology
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aReceptors, Interleukin-2 _ximmunology
650	0	4	_aRecombinant Fusion Proteins
650	0	4	_aSurvival Rate
650	0	4	_aTacrolimus _xtherapeutic use
700	1		_aStratta, R J
700	1		_aAlloway, R R
700	1		_aEgidi, M F
700	1		_aShokouh-Amiri, M H
700	1		_aGrewal, H P
700	1		_aGaber, A O
773	0		_tTransplantation proceedings _gvol. 33 _gno. 1-2 _gp. 1701-3
856	4	0	_uhttps://doi.org/10.1016/s0041-1345(00)02649-x _zAvailable from publisher's website
999			_c11203688 _d11203688